Company news
Conexeu Sciences Inc. (NASDAQ:CNXU) news
Conexeu Sciences Inc. news releases on 6ix. Latest, Oct 6, 2026: Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
Press releases & updates
Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
October 6, 2026
Conexeu Sciences Sets September and October 2026 Conference Schedule
September 1, 2026
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
August 11, 2026
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
July 13, 2026
Conexeu Sciences : Initial Statement of Beneficial Ownership (Form 3)
June 29, 2026
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
June 25, 2026
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
June 15, 2026
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
June 7, 2026
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
June 3, 2026
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 26, 2026
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
May 21, 2026